Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs

Eur J Pharmacol. 2015 Feb 15:749:73-80. doi: 10.1016/j.ejphar.2014.11.029. Epub 2014 Dec 4.

Abstract

Steroid-induced ocular hypertension (SIOH) is associated with topical and systemic use of steroids. However, SIOH-associated anterior and posterior segment morphological changes in rats have not been described widely. Here we describe the pattern of intraocular pressure (IOP) changes, quantitative assessment of trabecular meshwork (TM) and retinal morphological changes and changes in retinal redox status in response to chronic dexamethasone treatment in rats. We also evaluated the responsiveness of steroid-pretreated rat eyes to 5 different classes of antiglaucoma drugs that act by different mechanisms. Up to 80% of dexamethasone treated animals achieved significant and sustained IOP elevation. TM thickness was significantly increased and number of TM cells was significantly reduced in SIOH rats compared to the vehicle-treated rats. Quantitative assessment of retinal morphology showed significantly reduced thickness of ganglion cell layer (GCL) and inner retina (IR) in SIOH rats compared to vehicle-treated rats. Estimation of retinal antioxidants including catalase, superoxide dismutase and glutathione showed significantly increased retinal oxidative stress in SIOH animals. Furthermore, steroid-treated eyes showed significant IOP lowering in response to treatment with 5 different drug classes. This indicated the ability of SIOH eyes to respond to drugs acting by different mechanisms. In conclusion, SIOH was associated with significant morphological changes in TM and retina and retinal redox status. Additionally, SIOH eyes also showed IOP lowering in response to drugs that act by different mechanisms of action. Hence, SIOH rats appear to be an inexpensive and noninvasive model for studying the experimental antiglaucoma drugs for IOP lowering and neuroprotective effects.

Keywords: Histology; IOP; Rats; Retina; Steroid; Trabecular meshwork.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology
  • Brimonidine Tartrate
  • Catalase / metabolism
  • Dexamethasone / adverse effects*
  • Disease Models, Animal
  • Female
  • Glutathione / metabolism
  • Intraocular Pressure / drug effects
  • Latanoprost
  • Male
  • Ocular Hypertension / chemically induced*
  • Ocular Hypertension / metabolism
  • Ocular Hypertension / pathology
  • Ocular Hypertension / physiopathology
  • Oxidative Stress / drug effects
  • Pilocarpine / pharmacology
  • Prostaglandins F, Synthetic / pharmacology
  • Quinoxalines / pharmacology
  • Rats, Sprague-Dawley
  • Retina / drug effects*
  • Retina / metabolism
  • Retina / pathology
  • Sulfonamides / pharmacology
  • Superoxide Dismutase / metabolism
  • Thiophenes / pharmacology
  • Timolol / pharmacology

Substances

  • Antihypertensive Agents
  • Prostaglandins F, Synthetic
  • Quinoxalines
  • Sulfonamides
  • Thiophenes
  • Pilocarpine
  • Brimonidine Tartrate
  • Latanoprost
  • Dexamethasone
  • Timolol
  • dorzolamide
  • Catalase
  • Superoxide Dismutase
  • Glutathione